43
Views
0
CrossRef citations to date
0
Altmetric
Features

The Mouth-COVID-19 Connection: The Importance of the Oral Cavity for the Coronavirus Disease — Part II

REFERENCES

  • Marra MA, Jones SJM, Astell CR, et al. The genome sequence of the SARS-associated coronavirus. Science 2003 May 30;300(5624):1399–1404. doi:10.1126/science.1085953. Epub 2003 May 1.
  • Jin L, Lamster I, Greenspan J, Pitts N, Scully C, Warnakulasuriya S. Global burden of oral diseases: Emerging concepts, management and interplay with systemic health. Oral Dis 2016 Oct;22(7):609–619. doi:10.1111/odi.12428.
  • Molayem S, Pontes C. The mouth-COVID connection: Il-6 levels in periodontal disease — potential role in COVID-19-related respiratory complications. J Calif Dent Assoc 2020 Oct 48(10):485–499. doi: 10.35481/jcda-48-10-01.
  • Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B. Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci 2020 Mar 3;12(1):1–6. doi:10.1038/s41368-020-0075-9.
  • Warabi Y, Tobisawa S, Kawazoe T, et al. Effects of oral care on prolonged viral shedding in coronavirus disease 2019 (COVID-19). Spec Care Dent 2020 Sep;40(5):470–474. doi:10.1111/scd.12498.
  • Bao L, Zhang C, Dong J, Zhao L, Li Y, Sun J. Oral microbiome and SARS-CoV-2: Beware of lung co-infection. Front Microbiol 2020 Jul 31;11:1840. doi:10.3389/fmicb.2020.01840. eCollection 2020.
  • Sampson V, Kamona N, Sampson A. Could there be a link between oral hygiene and the severity of SARS-CoV-2 infections? Br Dent J 2020 Jun;228(12):971–975. doi:10.1038/s41415-020-1747-8.
  • Kirk-Bayley J, Challacombe S, Sunkaraneni V, Combes J. The use of povidone iodine nasal spray and mouthwash during the current COVID-19 pandemic may protect healthcare workers and reduce cross infection. SSRN Electron J March 2020. doi:10.2139/ssrn.3563092.
  • O’Donnell VB, Thomas D, Stanton R, et al. Potential role of oral rinses targeting the viral lipid envelope in SARS-CoV-2 infection. Function (Oxf) 2020;1(1):zqaa002. doi:10.1093/function/zqaa002. Epub 2020 Jun 5.
  • Marui VC, Souto MLS, Rovai ES, Romito GA, Chambrone L, Pannuti CM. Efficacy of preprocedural mouthrinses in the reduction of microorganisms in aerosol: A systematic review. J Am Dent Assoc 2019 Dec;150(12):1015–1026.e1. doi:10.1016/j.adaj.2019.06.024.
  • Yoneyama T, Yoshida M, Ohrui T, et al. Oral care reduces pneumonia in older patients in nursing homes. J Am Geriatr Soc 2002 Mar;50(3):430–433. doi:10.1046/j.1532-5415.2002.50106.x.
  • Mori H, Hirasawa H, Oda S, Shiga H, Matsuda K, Nakamura M. Oral care reduces incidence of ventilator-associated pneumonia in ICU populations. Intensive Care Med 2006 Feb;32(2):230–236. doi:10.1007/s00134-005-0014-4. Epub 2006 Jan 25.
  • Munro CL, Grap MJ, Elswick RK, McKinney J, Sessler CN, Hummel RS. Oral health status and development of ventilator-associated pneumonia: A descriptive study. Am J Crit Care 2006;15(5):453–460. doi:10.4037/ajcc2006.15.5.453.
  • de Carvalho Baptista IM, Martinho FC, Nascimento GG, da Rocha Santos CE, Prado RF do, Valera MC. Colonization of oropharynx and lower respiratory tract in critical patients: Risk of ventilator-associated pneumonia. Arch Oral Biol 2018 Jan;85:64–69. doi:10.1016/j.archoralbio.2017.09.029. Epub 2017 Oct 2.
  • Kumar PS. From focal sepsis to periodontal medicine: A century of exploring the role of the oral microbiome in systemic disease. J Physiol 2017 Jan 15;595(2):465–476. doi:10.1113/JP272427.
  • Winning L, Patterson CC, Cullen KM, Kee F, Linden GJ. Chronic periodontitis and reduced respiratory function. J Clin Periodontol 2019 Mar;46(3):266–275. doi:10.1111/jcpe.13076.
  • Hong CHL, Aung MM, Kanagasabai K, Lim CA, Liang S, Tan KS. The association between oral health status and respiratory pathogen colonization with pneumonia risk in institutionalized adults. Int J Dent Hyg 2018 May;16(2):e96–e102. doi:10.1111/idh.12321. Epub 2017 Nov 9.
  • Scannapieco FA, Bush RB, Paju S. Associations between periodontal disease and risk for nosocomial bacterial pneumonia and chronic obstructive pulmonary disease. A systematic review. Ann Periodontol 2003 Dec;8(1):54–69. doi:10.1902/annals.2003.8.1.54.
  • Abe S, Ishihara K, Adachi M, Sasaki H, Tanaka K, Okuda K. Professional oral care reduces influenza infection in elderly. Arch Gerontol Geriatr Sep-Oct 2006;43(2):157–64. doi: 10.1016/j.archger.2005.10.004. Epub 2005 Dec 2.
  • Imsand M, Janssens JP, Auckenthaler R, Mojon P, Budtz-Jørgensen E. Bronchopneumonia and oral health in hospitalized older patients. A pilot study. Gerodontology 2002 Dec;19(2):66–72. doi:10.1111/j.1741-2358.2002.00066.x.
  • Quagliarello V, Ginter S, Han L, Van Ness P, Allore H, Tinetti M. Modifiable risk factors for nursing home-acquired pneumonia. Clin Infect Dis 2005 Jan 1;40(1):1–6. doi: 10.1086/426023. Epub 2004 Dec 1.
  • Sjögren P, Nilsson E, Forsell M, Johansson O, Hoogstraate J. A systematic review of the preventive effect of oral hygiene on pneumonia and respiratory tract infection in elderly people in hospitals and nursing homes: Effect estimates and methodological quality of randomized controlled trials. J Am Geriatr Soc 2008 Nov;56(11):2124–2130. doi:10.1111/j.1532-5415.2008.01926.x.
  • Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020 Mar 28;395(10229):1054–1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
  • Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
  • Million M, Lagier JC, Gautret P, et al. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis May-Jun 2020;35:101738. doi:10.1016/j.tmaid.2020.101738.
  • Olsen I, Yamazaki K. Can oral bacteria affect the microbiome of the gut? J Oral Microbiol 2019 Mar 18;11(1):1586422. doi: 10.1080/20002297.2019.1586422. eCollection 2019.
  • Shen Z, Xiao Y, Kang L, et al. Genomic diversity of severe acute respiratory syndrome-coronavirus 2 in patients with coronavirus disease 2019. Clin Infect Dis 2020 Jul 28;71(15):713–720. doi:10.1093/cid/ciaa203.
  • Herrera D, Serrano J, Roldán S, Sanz M. Is the oral cavity relevant in SARS-CoV-2 pandemic? Clin Oral Investig 2020 Aug;24(8):2925–2930. doi:10.1007/s00784-020-03413-2.
  • Figuero E, Herrera D, Tobías A, et al. Efficacy of adjunctive anti-plaque chemical agents in managing gingivitis: A systematic review and network meta-analyses. J Clin Periodontol 2019 Jul;46(7):723–739. doi:10.1111/jcpe.13127.
  • Escribano M, Figuero E, Martín C, et al. Efficacy of adjunctive anti-plaque chemical agents: A systematic review and network meta-analyses of the Turesky modification of the Quigley and Hein plaque index. J Clin Periodontol 2016 Dec;43(12):1059–1073. doi:10.1111/jcpe.12616. Epub 2016 Oct 10.
  • Epstein JB, Chow K, Mathias R. Dental procedure aerosols and COVID-19. Lancet Infect Dis 2021 Apr;21(4):e73. doi: 10.1016/S1473-3099(20)30636-8. Epub 2020 Aug 10.
  • Bernstein D, Schiff G, Echler G, Prince A, Feller M, Briner W. In vitro virucidal effectiveness of a 0.12%-chlorhexidine gluconate mouthrinse. J Dent Res 1990 Mar;69(3):874–876. doi:10.1177/00220345900690030901.
  • Wood A, Payne D. The action of three antiseptics/disinfectants against enveloped and non-enveloped viruses. J Hosp Infect 1998 Apr;38(4):283–295. doi:10.1016/S0195-6701(98)90077-9.
  • Yoon JG, Yoon J, Song JY, et al. Clinical significance of a high SARS-CoV-2 viral load in the saliva. J Korean Med Sci 2020 May 25;35(20):e95. doi:10.3346/jkms.2020.35.e195.
  • Parhar HS, Tasche K, Brody RM, et al. Topical preparations to reduce SARS-CoV-2 aerosolization in head and neck mucosal surgery. Head Neck 2020 Jun;42(6):1268–1272. doi:10.1002/hed.26200. Epub 2020 Apr 25.
  • Bidra AS, Pelletier JS, Westover JB, Frank S, Brown SM, Tessema B. Rapid in vitro inactivation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using povidone-iodine oral antiseptic rinse. J Prosthodont 2020 Jul;29(6):529–533. doi:10.1111/jopr.13209. Epub 202 Jun 16.
  • Popkin DL, Zilka S, Dimaano M, et al. Cetylpyridinium chloride (CPC) exhibits potent, rapid activity against influenza viruses in vitro and in vivo. Pathog Immun 2017;2(2):252. doi:10.20411/pai.v2i2.200. Epub 2017 Jun 26.
  • Mukherjee PK, Esper F, Buchheit K, et al. Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections. BMC Infect Dis 2017 Jan;17(1):74. doi:10.1186/s12879-016-2177-8.
  • Dennison DK, Meredith GM, Shillitoe EJ, Caffesse RG. The antiviral spectrum of Listerine antiseptic. Oral Surg Oral Med Oral Pathol Oral Radiol 1995;79(4):442–448. doi:10.1016/S1079-2104(05)80124-6.
  • Meiller TF, Silva A, Ferreira SM, Jabra-Rizk MA, Kelley JI, DePaola LG. Efficacy of Listerine antiseptic in reducing viral contamination of saliva. J Clin Periodontol 2005 Apr;32(4):341–346. doi:10.1111/j.1600-051X.2005.00673.x.
  • Gusberti FA, Sampathkumar P, Siegrist BE, Lang NP. Microbiological and clinical effects of chlorhexidine digluconate and hydrogen peroxide mouthrinses on developing plaque and gingivitis. J Clin Periodontol 1988 Jan;15(1):60–67. doi:10.1111/j.1600-051X.1988.tb01556.x.
  • Omidbakhsh N, Sattar SA. Broad-spectrum microbicidal activity, toxicologic assessment, and materials compatibility of a new generation of accelerated hydrogen peroxide-based environmental surface disinfectant. Am J Infect Control 2006 Jun;34(5):251–257. doi:10.1016/j.ajic.2005.06.002.
  • Jamal M, Shah M, Almarzooqi SH, et al. Overview of transnational recommendations for COVID-19 transmission control in dental care settings. Oral Dis 2021 Apr;27 Suppl 3:655–664. doi: 10.1111/odi.13431. Epub 2020 Jun 3.
  • Bidra AS, Pelletier JS, Westover JB, Frank S, Brown SM, Tessema B. Comparison of in vitro inactivation of SARS CoV-2 with hydrogen peroxide and povidone-iodine oral antiseptic rinses. J Prosthodont 2020 Aug;29(7):599–603. doi:10.1111/jopr.13220. Epub 2020 Jul 24.
  • Meister TL, Brüggemann Y, Todt D, et al. Virucidal efficacy of different oral rinses against severe acute respiratory syndrome coronavirus 2. J Infect Dis 2020 Sep 14;222(8):1289–1292. doi:10.1093/infdis/jiaa471.
  • Herold T, Jurinovic V, Arnreich C, et al. Elevated level of IL-6 predicts respiratory failure in hospitalized symptomatic COVID-19 patients. J Allergy Clin Immunol 2020 Jul;146(1):128–136.e4. doi: 10.1016/j.jaci.2020.05.008. Epub 2020 May 18.
  • Matsushima K, Ohbayashi E, Takeuchi H, Hosoya S, Abiko Y, Yamazaki M. Stimulation of interleukin-6 production in human dental pulp cells by peptidoglycans from lactobacillus casei. J Endod 1998 Apr;24(4):252–255. doi:10.1016/S0099-2399(98)80107-6.
  • De Sá AR, Garcia Santos Pimenta FJ, Dutra WO, Gomez RS. Immunolocalization of interleukin 4, interleukin 6, and lymphotoxin α in dental granulomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003 Sep;96(3):356–360. doi:10.1016/S1079-2104(03)00067-2.
  • Gomes MS, Blattner TC, Sant’Ana Filho M, et al. Can apical periodontitis modify systemic levels of inflammatory markers? A systematic review and meta-analysis. J Endod 2013 Oct;39(10):1205–1217. doi:10.1016/j.joen.2013.06.014. Epub 2013 Aug 16.
  • Nibali L, Fedele S, D’Aiuto F, Donos N. Interleukin-6 in oral diseases: A review. Oral Dis 2012 Apr;18(3):236–243. doi:10.1111/j.1601-0825.2011.01867.x. Epub 2011 Nov 4.
  • Azuma MM, Samuel RO, Gomes-Filho JE, Dezan-Junior E, Cintra LTA. The role of IL-6 on apical periodontitis: A systematic review. Int Endod J 2014 Jul;47(7):615–621. doi:10.1111/iej.12196.
  • Mozaffari HR, Sharifi R, Sadeghi M. Interleukin-6 levels in the serum and saliva of patients with oral lichen planus compared with healthy controls: A meta-analysis study. Cent Eur J Immunol 2018;43(1):103–108. doi:10.5114/ceji.2018.74880. Epub 2018 Mar 30.
  • Larsen KR, Johansen JD, Reibel J, Zachariae C, Pedersen AML. Serum cytokine profile and clinicopathological findings in oral lichen planus, oral lichenoid lesions and stomatitis. Clin Exp Dent Res 2017 Nov 7;3(6):220–226. doi:10.1002/cre2.91. eCollection 2017 Dec.
  • Rhodus NL, Cheng B, Bowles W, Myers S, Miller L, Ondrey F. Proinflammatory cytokine levels in saliva before and after treatment of (erosive) oral lichen planus with dexamethasone. Oral Dis 2006 Mar;12(2):112–116. doi:10.1111/j.1601-0825.2005.01165.x.
  • Rezaei F, Mozaffari HR, Tavasoli J, Zavattaro E, Imani MM, Sadeghi M. Evaluation of serum and salivary interleukin-6 and interleukin-8 levels in oral squamous cell carcinoma patients: Systematic review and meta-analysis. J Interf Cytokine Res 2019 Dec;39(12):727–739. doi:10.1089/jir.2019.0070. Epub 2019 Jul 17.
  • Kheirandish-Gozal L, Gozal D. Obstructive sleep apnea and inflammation: Proof of concept based on two illustrative cytokines. Int J Mol Sci 2019 Jan 22;20(3):459. doi:10.3390/ijms20030459.
  • Vicente E, Marin JM, Carrizo SJ, et al. Upper airway and systemic inflammation in obstructive sleep apnoea. Eur Respir J 2016 Oct;48(4):1108–1117. doi:10.1183/13993003.00234-2016. Epub 2016 Sep 1.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.